Takeda Pharmaceutical Co Ltd ADR (TAK)
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical Co Ltd ADR is a Healthcare company with a market capitalization of $50.27B and a dividend yield of 4.16%.
5-Year Price History
Latest Annual Financials · FY ending March 31, 2026 · in JPY
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q3 2025 | January 29, 2026 | $0.21 | — | — |
| Q2 2025 | October 30, 2025 | $-0.03 | $0.15 | -116.8% |
| Q1 2025 | July 30, 2025 | $151.00 | $0.20 | +75174.2% |
| Q4 2025 | June 25, 2025 | $-0.23 | $-0.17 | -37.1% |
| Q3 2024 | January 30, 2025 | $0.05 | $0.63 | -92.4% |
| Q2 2024 | October 31, 2024 | $29.07 | $87.45 | -66.8% |
Other Drug Manufacturers - Specialty & Generic Stocks
Frequently Asked Questions
What is Takeda Pharmaceutical Co Ltd ADR's market cap?
As of June 29, 2026, Takeda Pharmaceutical Co Ltd ADR (TAK) has a market capitalization of $50.27B.
Does Takeda Pharmaceutical Co Ltd ADR pay a dividend?
Yes — Takeda Pharmaceutical Co Ltd ADR pays a dividend yielding 4.16%, an annual payout of $200.00 per share.
What sector is TAK in?
Takeda Pharmaceutical Co Ltd ADR is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
What was Takeda Pharmaceutical Co Ltd ADR's revenue?
In its latest reported fiscal year (ending March 31, 2026), Takeda Pharmaceutical Co Ltd ADR reported revenue of 4.78T JPY and net income of 203.33B JPY.
Ask your own questions about TAK
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.